BCL2 and B-cell chronic lymphocytic leukemia: A flow cytometric approach involving CLL cells labeled with a division-tracking fluorescent dye [2] and fluorescent staining of intracellular proteins permitted the quantitative monitoring of BCL2/MCL1/survivin and p53 proteins as activated CLL cells progressed through sequential cell divisions.